Neuropsychiatric, Neurocognitive And Quality Of Life Outcomes In Patients With Epilepsy Treated With Levetiracetam (Keppra) Verses Older AEDs As First Substitution Monotherapy.

Trial Profile

Neuropsychiatric, Neurocognitive And Quality Of Life Outcomes In Patients With Epilepsy Treated With Levetiracetam (Keppra) Verses Older AEDs As First Substitution Monotherapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Carbamazepine; Levetiracetam; Valproic acid
  • Indications Partial epilepsies
  • Focus Therapeutic Use
  • Acronyms KONQUEST
  • Most Recent Events

    • 03 Sep 2012 The published results stated the original target enrollment in the study was 150.
    • 03 Sep 2012 Status changed from recruiting to completed.
    • 03 Sep 2012 The published results stated that patients were enrolled over a 23-month period from Feb 15 2006 to Dec 23 2008
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top